Loading provider…
Loading provider…
Medical Oncology Physician in Baltimore, MD
NPI: 1124511092Primary Practice Location
JOHNS HOPKINS BAYVIEW MEDICAL CENTER
4940 Eastern Ave, Baltimore, MD
Primary Employer
Jhu - Oncology
hopkinsmedicine.org
HQ Phone
Get MD Aliyah's Phone Numberphone_androidMobile
Get MD Aliyah's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 11 | 14 |
Authors: Meyers, Daniel E, Pasternak, Meghann, Dolter, Samantha, Grosjean, Heidi A I, Lim, Chloe A, Stukalin, Igor, Goutam, Siddhartha, Navani, Vishal, Heng, Daniel Y C, Cheung, Winson Y, Morris, Don G, Pabani, Aliyah
Journal: JTO Clin Res Rep
Publication Date: 2023-02-24
Real-world survival outcomes, treatment patterns, and impact of PD-L1 expression among patients with unresectable, stage III NSCLC treated with CRT → durvalumab in Canada: The RELEVANCE study.
Authors: Paul Wheatley Price, Vishal Navani, Aliyah Pabani, Bertrand Routy, Stephanie Snow, Marie-hélène Denault, Yongjin Kim, Iqra Syed, Natalie Devost, Daphne Hui, Rana Qadeer, Paul Arora, Russanthy Velummailum, Aaron Springford, Chelsea Mckibbon, Cheryl Ho
Publication Date: 2024-09-24
Scoping review protocol on the impact of antimicrobial resistance on cancer management and outcomes.
Authors: Bratti, Vanessa F, Wilson, Brooke E, Fazelzad, Rouhi, Pabani, Aliyah, Zurn, Shalini J, Johnson, Sonali, Sung, Lillian, Rodin, Danielle
Journal: BMJ Open
Publication Date: 2023-02-06
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, PROCEDURE: Magnetic Resonance Imaging, BIOLOGICAL: Pembrolizumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, PROCEDURE: Computed Tomography, DRUG: Pemetrexed
Lead Sponsor: Takeda
Intervention / Treatment: DRUG: Carboplatin, DRUG: Cisplatin, DRUG: Pemetrexed, DRUG: TAK-788